15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Chemed Corp, 1 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $436.00 to $510.00, so the covering firms are broadly aligned. The average target of $480.25 sits 7% below the current $516.40. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $6.02 next quarter toward $26.88 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy125%
Hold375%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Chemed Corp.
As of Jul, 1 of 4 firms rate CHE a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CHE EPS & revenue forecast
EPS · NEXT QUARTER
$6.02
Range $5.89 – $6.21 · 4 analysts · +14% YoY
Next period, 4 analysts expect Chemed Corp to earn $6.02 a share (range $5.89 – $6.21), versus $5.27 a year earlier. Full-year consensus is $24.34, growing to $26.88 the year after.
REVENUE · NEXT QUARTER
$674.1M
Range $669.5M – $676.6M · 4 analysts · +8% YoY
Revenue is expected to reach $674.1M (range $669.5M – $676.6M), +7.9% year-over-year. Full-year consensus is $2.7B, rising to $2.9B next year.
Top analysts covering Chemed Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CHE.
#1
Ben Hendrix
RBC Capital · Rank #117
Hold
$436.00-15.6% to target
Overall win rate
44%
+ Follow
#2
Joanna Gajuk
B of A Securities
Hold
$510.00-1.2% to target
Coverage
—
+ Follow
#3
Brian Tanquilut
Jefferies
Hold
$400.00-22.5% to target
Coverage
—
+ Follow
#4
Michael Wiederhorn
Oppenheimer
Buy
$500.00-3.2% to target
Coverage
—
+ Follow
CHE stock forecast FAQ
What is CHE's average 12-month price target?+
The 4 analysts with a live target average $480.25 for Chemed Corp over the next 12 months, ranging from a $510.00 high to a $436.00 low.
Is CHE stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 1 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CHE?+
The Street-high target is $510.00 (B of A Securities), and the Street-low is $436.00 (RBC Capital). The average of all 4 active targets is $480.25.
How many Wall Street analysts cover CHE?+
4 analysts have an active rating on Chemed Corp, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering CHE?+
Among analysts who currently cover CHE, Ben Hendrix of RBC Capital has the strongest overall Quantellect track record (Rank #117). Their current call is Hold with a $436.00 target.
What is Chemed Corp's projected EPS for next quarter?+
The consensus estimate is $6.02 per share (range $5.89 – $6.21) across 4 analysts. Full-year EPS is projected at $24.34, rising to $26.88 the following year.
How much revenue is Chemed Corp expected to report next quarter?+
Consensus revenue is $674.1M (range $669.5M – $676.6M). Full-year revenue is projected at $2.7B, growing to $2.9B next year.
Have analysts been upgrading or downgrading CHE lately?+
As of Jul, 1 of 4 firms rate CHE a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CHE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
